Skip to Content

MD Anderson Events

Hematology Grand Rounds

Hematology Grand Rounds

Hematology Grand Rounds

 
Department of Lymphoma/Myeloma
In Collaboration with the
Department of Leukemia and Department of Stem Cell Transplantation
 
 
Andy Evens, M.D.
Chief, Hematology/Oncology, Tufts Medical Center
 
 
Presenting
 
“The Prognosis and Treatment of Hodgkin Lymphoma in 2014”
 
Wednesday, August 27, 2014
8:00 a.m. – 9:00 a.m.
Pickens Tower, 3rd Floor, Rooms 1, 2, 7 & 8
 
After attending this activity, the target audience of Physicians from Leukemia, Lymphoma/Myeloma, Stem Cell Transplantation and Research Staff, Nurses, Data Coordinators, Laboratory Staff, Post-Doctoral Fellows, Instructors, and Research Staff in Lab should be able to:
 
  • Assess clinical and translational research in lymphoma and plasma cell dyscrasia (knowledge);
  • Increase collaboration between disciplines regarding lymphoma and plasma cell dyscrasia (knowledge, competence, performance);
  • Update knowledge and collaboration in trials and research (knowledge, competence, performance);
  • Accelerate the speed of translational research and clinical trials to achieve better patient outcomes (knowledge, competence, performance, patient outcomes);
 
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of The University of Texas MD Anderson Cancer Center that the program chair(s), planning committee member, faculty/teacher/ author, or CME activity reviewer must disclose any relevant financial relationships with commercial interests whose products may be discussed in the activities, if any.  MD Anderson also requires that faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products.  Specific disclosure will be made to the participants prior to the educational activity.               
                                                                                                                                                                                                                                                                               

Date: 8/27/14, 8am to 9am
Time: 8/27/14, 8am to 9am
Location: Pickens Academic Tower, Floor 3, Room 1 (FCT3.4167)
Format: Grand Rounds
CME: 1.0
Facilitator: Laura Lam
Speaker: Andrew Evens
Speaker Bio: Following graduation with honors from the Chicago College of Osteopathic Medicine at Midwestern University, Dr. Evens completed his Internal Medicine residency at Lutheran General Hospital and he served an additional year as Chief Medical Resident. Dr. Evens subsequently completed his Hematology/Oncology fellowship at Northwestern University Feinberg School of Medicine and The Robert H. Lurie Comprehensive Cancer Center. During fellowship, Dr. Evens also completed a Masters of Science in Clinical Investigation at Northwestern University. He is board certified in Hematology and Medical Oncology. Dr. Evens was a faculty member in the Division of Hematology/Oncology at Northwestern University through December 2010. He subsequently was a faculty member at University of Massachusetts Medical School and the UMass Memorial Cancer Center where he served as the Deputy Director for Clinical and Translational Research. At Tufts Medical Center, Dr. Evens is the Chief of the Division of Hematology/Oncology and Director of the Tufts Cancer Center; he is Professor of Medicine at Tufts University School of Medicine.
Contact: Sue Yi - sjyi@mdanderson.org